hypertension

New artificial intelligence tool diagnoses masked hypertension

byย University of Arkansas ย Editors’ notes ย The GIST Add as preferred source William Richardson, an associate professor of chemical engineering, developed AI diagnostic tools to find cases of masked hypertension. Credit: University of Arkansas About 10% of people with hypertension have normal blood pressure readings at the doctor’s office. Now researchers at the University of Arkansas […]

New artificial intelligence tool diagnoses masked hypertension Read More ยป

Hypertension affects the brain much earlier than expected, study suggests

byย Weill Cornell Medical College edited byย Gaby Clark, reviewed byย Robert Egan ย Editors’ notes In the brain cortex of mice (left) without hypertension, few endothelial cells (yellow) show aging or senescence (blue). After angiotensin is administered, which causes hypertension (middle), many more endothelial cells (blue) with aging and damage are present in the cortex. Blocking angiotensin receptors

Hypertension affects the brain much earlier than expected, study suggests Read More ยป

Apple Watch Hypertension Alert Moves BP Clues From Clinic to Wrist

  Hypertensionย affects more than 1.3 billion adults worldwide. Yet, its often silent nature means it may go undetected for years. In-office blood pressure measurements once or twice a year may also miss it. Could the Apple Watch hypertension notification feature, recently cleared by the US FDA, help address this diagnosis gap? โ€œThis kind of technology

Apple Watch Hypertension Alert Moves BP Clues From Clinic to Wrist Read More ยป

Biologic drug reduces symptoms and hospitalization for severe pulmonary hypertension after diagnosis in clinical trial

byย University of Michigan edited byย Stephanie Baum, reviewed byย Robert Egan ย Editors’ notes Credit: Unsplash/CC0 Public Domain Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension significantly reduces the likelihood of worsening disease when added within the first year after diagnosis, according to a study published in theย New England Journal

Biologic drug reduces symptoms and hospitalization for severe pulmonary hypertension after diagnosis in clinical trial Read More ยป

Stepping Down Hypertensive Therapy Is Not Beneficial in Frail, Older Adult Patients

Compared with usual care, stepping down antihypertensive therapy in nursing home patients aged 80 years and older did not yield any reduction in major adverse events or correlate with any other clinical benefit in the multicenter, randomized RETREAT-FRAIL trial. These findings conflict with prior observational studies predicting fewer adverse events and perhaps even a mortality

Stepping Down Hypertensive Therapy Is Not Beneficial in Frail, Older Adult Patients Read More ยป

Do no harm: Rethink treating diabetes, hypertension in frail older adults

byย Florida Atlantic University edited byย Gaby Clark, reviewed byย Andrew Zinin When treatment for chronic conditions in older adults becomes overly aggressive, it can do more harm than good. Credit: Alex Dolce, Florida Atlantic University Effectively managing chronic conditions like diabetes and hypertension can greatly improve quality of life, reduce complications and extend longevity for older adults.

Do no harm: Rethink treating diabetes, hypertension in frail older adults Read More ยป

Screen All With Hypertension for Primary Aldosteronism

July 14, 2025San Francisco โ€” All individuals with hypertension should be screened for primary aldosteronism (PA), according to a new clinical practice guideline from the Endocrine Society. The recommendation is to screen everyone with hypertension by measuring aldosterone and renin and to use the aldosterone to renin ratio to guide clinical care with either medication

Screen All With Hypertension for Primary Aldosteronism Read More ยป

Largest phase 3 trial of novel treatment for hypertension shows promising results

Queen Mary University of London FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with uncontrolled or resistant hypertension, according to the results of a phase 3 trial announced today.ย  LONDON, UK โ€“ 24 May 2025ย โ€“ The

Largest phase 3 trial of novel treatment for hypertension shows promising results Read More ยป

New cell signaling pathway found to shield blood vessels from hypertension damage

byย Lund University edited byย Stephanie Baum, reviewed byย Andrew Zinin ย  Age-dependent remodeling of the transcriptomes of human arteries. Credit:ย Journal of Biological Chemistryย (2025). DOI: 10.1016/j.jbc.2025.108400 By creating artificial aging in mice, researchers at Lund University in Sweden have been able to track the formation of aneurysms in the walls of blood vessels. One finding of the study,

New cell signaling pathway found to shield blood vessels from hypertension damage Read More ยป

FDA Approves Triple Rx for Hypertension

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults. Widaplik combines three drugs โ€” telmisartan, amlodipine, and indapamide โ€” into a single pill that will be available in three doses: 10/1.25/0.625 mg; 20/2.5/1.25 mg, and 40/5/2.5 mg. Intended as initial therapy for patients likely to need multiple medications to

FDA Approves Triple Rx for Hypertension Read More ยป

Scroll to Top